Quanome (QNME) traded down -7.45 % during a 24 hours period ending at 10:35 PM Central Europe on Monday 26th. One Quanome stock can currently be bought for about USD 0.42 on popular exchanges. Current supply of Quanome stocks is 34.4 mn. Quanome has a current market capitalization of USD 14.1 mn and approximately USD 55.1 k worth of Quanome was traded on exchanges in the last 24 hours. Since last month end, Quanome has traded -49.07 % down. Simple moving average of last 200 days is at USD 0.6. The highest price of past 52 weeks was recorded at USD 1.4 on 09/22/2026. 52 weeks low was at USD 0.25 on 07/29/2026.
Here is how related stocks have performed in the past 24 hours:
Scilex (SCLX) traded down -4.86 % and now trades at USD 2.33. Current market capitalisation for Scilex is USD 16.5 mn.
Greenland (GTEC) traded up 1.82 % and now trades at USD 0.63. Current market capitalisation for Greenland is USD 16.3 mn. Current price/earnings ratio for Greenland is 1.27.
Cytosorbents (CTSO) traded down -12.31 % and now trades at USD 4.47. Cytosorbents has a market capitalisation of USD 16.6 mn.
Mannatech (MTEX) traded down -1.29 % and now trades at USD 8.64. Mannatech has a market capitalisation of USD 16.3 mn.
Access Newswire (ACCS) traded down -4.38 % and now trades at USD 4.18. Access Newswire has a market capitalisation of USD 16.7 mn. ACCESS Newswire reported that ELEKTROS Inc. is evaluating a potential lithium property in northern New York, close to the Canadian border. The company notes that the site is not yet acquired or producing and that further consideration will involve checks of ownership, mineral‑rights status, geological data, independent sampling, environmental and permitting requirements, infrastructure and refining access. Management emphasizes that any potential acquisition or exploration remains hypothetical until these factors are clarified and that the company has no current military contract or confirmed production schedule. The company’s separate patent‑based electric‑vehicle charging technology is also under review for development partners and testing, but no commercialization progress has been announced. No concrete figures are provided, and the report highlights that the lithium opportunity is exploratory and subject to the usual uncertainties of early‑stage resource development.